Overmedication in COVID-19 Context: A Report From Peru.

IF 2.4 4区医学 Q3 PHARMACOLOGY & PHARMACY

Journal of clinical pharmacology Pub Date : 2020-09-01 Epub Date: 2020-07-21 DOI:10.1002/jcph.1704

Raisa N Martinez-Rivera, Alvaro Taype-Rondan

引用次数: 7

查看原文本刊更多论文

COVID-19背景下的过度用药:来自秘鲁的报告。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of clinical pharmacology 医学-药学

CiteScore

5.10

自引率

3.40%

发文量

176

审稿时长

2 months

期刊介绍： The Journal of Clinical Pharmacology (JCP) is a Human Pharmacology journal designed to provide physicians, pharmacists, research scientists, regulatory scientists, drug developers and academic colleagues a forum to present research in all aspects of Clinical Pharmacology. This includes original research in pharmacokinetics, pharmacogenetics/pharmacogenomics, pharmacometrics, physiologic based pharmacokinetic modeling, drug interactions, therapeutic drug monitoring, regulatory sciences (including unique methods of data analysis), special population studies, drug development, pharmacovigilance, womens’ health, pediatric pharmacology, and pharmacodynamics. Additionally, JCP publishes review articles, commentaries and educational manuscripts. The Journal also serves as an instrument to disseminate Public Policy statements from the American College of Clinical Pharmacology.